WDC

How to attend Turner Pope Investments Investor Evening – Monday 13th May 2019

Turner Pope Investments will be holding an Investor Evening this Monday 13th May 2019. With spaces limited it is important you reserve your spot via the email address at bottom...

WideCells Group PLC New Media Business Created

WideCells Group PLC (LON: WDC) has today announced that it has created a division encompassing a new media and technology business focussed on providing online marketing, content and technology driven..

WideCells Group PLC New Board members bring a wide range of business, corporate & capital market experience

WideCells Group PLC (LON:WDC), announced that, following the issuance of the Prospectus on 22 February 2019, Mr. David Sefton, who has a significant financial interest in the Company through the..

WideCells Group PLC CellPlan extends reach with Smart Cells deal

WideCells Group PLC (LON:WDC), the healthcare services group focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that its stem cell healthcare insurance..

WideCells Group PLC Get Conviction Buy Stance from Align Research

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that following the Group’s recent placing,..

Widecells Group PLC Q&A with CEO João Andrade & CFO David Bridgland (LON:WDC)

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chief Financial Officer David Bridgland caught up with DirectorsTalk for an exclusive interview to discuss why their shares were suspended,..

INTERVIEW: Widecells Group Placing and Looking ahead

Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything..

WideCells Group PLC Placing Update and Financial Position

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today provided the following update on its financial..

WideCells Group PLC Audited Preliminary Results

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announced today its audited preliminary results for the period..

Widecells Group PLC Q&A: CellPlan Agreement with Cryoviva

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade caught up with DirectorsTalk for an exclusive interview to discuss their agreement with Cryoviva Group to sell their stem cell insurance..

INTERVIEW: Widecells Group Increase Global Reach with Cryoviva Deal

Widecells Group Plc (LON:WDC) CEO João Andrade talks to DirectorsTalk about a landmark deal to launch it’s CellPlan insurance product in Asia. João explains who Cryoviva are, the impact this..

WideCells Group PLC Landmark deal to launch CellPlan insurance product in Asia

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that it has signed an agreement..

Widecells Group PLC Q&A: Knowledge Transfer Partnership (LON:WDC)

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chief Scientific Officer Peter Hollands caught up with DirectorsTalk for an exclusive interview to discuss the Innovate UK Knowledge Transfer..

INTERVIEW: Widecells Group to produce Stem Cells from Adults

Widecells Group plc (LON:WDC) CEO João Andrade and CSO Peter Hollands talk to DirectorsTalk about a government-backed Innovate UK Knowledge Transfer Partnership with Manchester Metropolitan University (MMU) to undertake research..

WideCells Group PLC Granted Innovate UK KTP for Stem Cell Research

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that its 100% owned stem cell..

Widecells Group PLC Q&A with CEO João Andrade & CSO Professor Peter Hollands

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chief Scientific Officer Professor Peter Hollands caught up with DirectorsTalk for an exclusive interview to discuss the licence awarded from..

Widecells Group PLC Q&A with CEO João Andrade and Chairman Peter Presland

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chairman Peter Presland caught up with DirectorsTalk for an exclusive interview to discuss the recent Board changes, the launch of..

INTERVIEW: Widecells Group Plc HTA Award and the Benefits

Widecells Group Plc (LON:WDC) CEO João Andrade and CSO Prof Peter Hollands talk to DirectorsTalk about being awarded a licence from the Human Tissue Authority, what it means for the..

WideCells Group PLC Licence Award from the Human Tissue Authority

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that the UK’s Human Tissue Authority..

INTERVIEW: Widecells Group Strengthen Board and Update

Widecells Group Plc (LON:WDC) CEO João Andrade and new Chairman Peter Presland join DirectorsTalk to discuss its latest update. João explains the reasons behind the board changes, what wideacademy is,..

Search

Funds

WDC

Search

Funds

WDC

FTSE 100

Funds